176 related articles for article (PubMed ID: 21622260)
1. RAGE during infectious diseases.
van Zoelen MA; Achouiti A; van der Poll T
Front Biosci (Schol Ed); 2011 Jun; 3(3):1119-32. PubMed ID: 21622260
[TBL] [Abstract][Full Text] [Related]
2. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
3. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia.
Achouiti A; de Vos AF; de Beer R; Florquin S; van 't Veer C; van der Poll T
J Innate Immun; 2013; 5(6):603-12. PubMed ID: 23774862
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
5. The role of receptor for advanced glycation endproducts (RAGE) in infection.
van Zoelen MA; Achouiti A; van der Poll T
Crit Care; 2011; 15(2):208. PubMed ID: 21457506
[No Abstract] [Full Text] [Related]
6. RAGE in inflammation: a new therapeutic target?
Bierhaus A; Stern DM; Nawroth PP
Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
[TBL] [Abstract][Full Text] [Related]
7. Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.
Srikrishna G; Nayak J; Weigle B; Temme A; Foell D; Hazelwood L; Olsson A; Volkmann N; Hanein D; Freeze HH
J Cell Biochem; 2010 Jun; 110(3):645-59. PubMed ID: 20512925
[TBL] [Abstract][Full Text] [Related]
8. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
9. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
Mosquera JA
Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
[TBL] [Abstract][Full Text] [Related]
10. S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling.
Villarreal A; Aviles Reyes RX; Angelo MF; Reines AG; Ramos AJ
J Neurochem; 2011 Apr; 117(2):321-32. PubMed ID: 21291473
[TBL] [Abstract][Full Text] [Related]
11. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
12. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules.
Foell D; Wittkowski H; Vogl T; Roth J
J Leukoc Biol; 2007 Jan; 81(1):28-37. PubMed ID: 16943388
[TBL] [Abstract][Full Text] [Related]
13. The role of RAGE in host pathology and crosstalk between RAGE and TLR4 in innate immune signal transduction pathways.
Prantner D; Nallar S; Vogel SN
FASEB J; 2020 Dec; 34(12):15659-15674. PubMed ID: 33131091
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 and RAGE in inflammation and cancer.
Sims GP; Rowe DC; Rietdijk ST; Herbst R; Coyle AJ
Annu Rev Immunol; 2010; 28():367-88. PubMed ID: 20192808
[TBL] [Abstract][Full Text] [Related]
15. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
16. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
Rao NV; Argyle B; Xu X; Reynolds PR; Walenga JM; Prechel M; Prestwich GD; MacArthur RB; Walters BB; Hoidal JR; Kennedy TP
Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
[TBL] [Abstract][Full Text] [Related]
17. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.
Sirois CM; Jin T; Miller AL; Bertheloot D; Nakamura H; Horvath GL; Mian A; Jiang J; Schrum J; Bossaller L; Pelka K; Garbi N; Brewah Y; Tian J; Chang C; Chowdhury PS; Sims GP; Kolbeck R; Coyle AJ; Humbles AA; Xiao TS; Latz E
J Exp Med; 2013 Oct; 210(11):2447-63. PubMed ID: 24081950
[TBL] [Abstract][Full Text] [Related]
18. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
Donato R
Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line.
Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y
J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983
[TBL] [Abstract][Full Text] [Related]
20. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.
Bopp C; Bierhaus A; Hofer S; Bouchon A; Nawroth PP; Martin E; Weigand MA
Crit Care; 2008; 12(1):201. PubMed ID: 18226173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
